Cell cycle analysis of 932 flow cytometric DNA histograms of fresh frozen breast carcinoma material: Correlations between flow cytometric, clinical, and pathologic variables

Cancer

Volumn 77, Issue 11, 1996, Pages 2258-2266

  Bergers, Elisabeth ^a   Van Diest, Paul J ^a   Baak, Jan P A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

breast carcinoma; cell cycle variables; clinicopathologic variables; flow cytometry

Indexed keywords

STEROID RECEPTOR;

ADULT; ARTICLE; BREAST CARCINOMA; CELL CYCLE; CELL CYCLE S PHASE; CLINICAL FEATURE; CLINICAL TRIAL; FEMALE; FLOW CYTOMETRY; HISTOGRAM; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS RATE; MULTICENTER STUDY; PLOIDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHATIC METASTASIS; MENOPAUSE; MIDDLE AGED; MITOTIC INDEX; PLOIDIES; PROGNOSIS; REPRODUCIBILITY OF RESULTS; S PHASE;

EID: 0029894216     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2258::AID-CNCR12>3.0.CO;2-W     Document Type: Article

References (54)

1. Beerman H, Kluin PhM, Hermans J, Velde CJH van de, Cornelisse CJ. Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients. Int J Cancer 1990; 45:34-9.
2. Bosari S, Lee AKC, Tahan SR, Figoni MAT, Wiley BD, Heatley GJ, et al. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma. Cancer 1992; 70:1943-50.
3. Clark GM, Dressier LG, Owens MA, Pounds G, Oldaker T, Mcguire WL. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 1989; 320:627-3.
4. Cornelisse CJ, Velde van de CJH, Caspers RJC, Moolenaar AJ, Hermans J. DNA ploidy and survival in breast cancer patients. Cytometry 1987; 8:225-34.
5. Fisher B, Gunduz N, Costantino J, Fisher ER, Redmond C, Mamounas EP, et al. DNA flow cytometric analysis of primary operable breast cancer. Cancer 1991; 68:1465-75.
6. Friedlander ML, Hedley DW, Taylor IW. Clinical and biological significance of aneuploidy in human tumours. J Clin Pathol 1984; 37:961-74.
7. Joensuu H, Toikkanen S, Hemi PJ. DNA Index and S-phase fraction and their combination as prognostic factors in operable ductal breast carcinoma. Cancer 1990; 66:331-40.
8. Kallioniemi OP, Hietanen T, Mattila J, Lehtinen M, Lauslahti K, Koivula T. Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer. Eur J Cancer Clin Oncol 1987; 23:277-82.
9. Kallioniemi OP, Blanco G, Alavaikko M, Hietanen T, Mattila J, Lauslahti K. Tumour DNA ploidy as an independent prognostic factor in breast cancer. Br J Cancer 1987; 56:637-42.
10. Kallioniemi OP, Blanco G, Alavaikko M, Hietanen T, Mattila J, Lauslahti K, et al. Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. Cancer 1988; 62:2183-90.
11. Uyterlinde AM, Schipper NW, Baak JPA. Comparison of extent of disease and morphometric and DNA flow cytometric prognostic factors in invasive ductal breast cancer. J Clin Pathol 1987; 40:1432-6.
12. Uyterlinde AM, Baak JPA, Schipper NW, Peterse H, Matze E, Meijer CJL. Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breastcancer patients with long follow-up. Int J Cancer 1990; 45:1-7, 11.
13. Baildam AD, Zaloudik J, Howell A, Barnes DM, Turnbull L, Swindell R, et al. DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast. Br J Cancer 1987; 55:553-9.
14. Keyhani-Rofagha S, O'Toole RV, Farrar WB, Sickle-Santanello B, DeCenzo J, Young D. Is DNA ploidy an independent prognostic indicator in infiltrative node-negative breast adenocarcinoma? Cancer 1990; 65:1577-82.
15. Muss HB, Kute TE, Smith LR, Booher C, Long R, Kammire L, et al. The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer. Cancer 1989; 64:1894-900.
16. Owainati AAR, Robins RA, Hinten C, Ellis IO, Dowle CS, Ferry B, et al. Tumour aneuploidy, prognostic parameters and survival in primary breast cancer. Br J Cancer 1987; 55:449-54.
17. O'Reilly SM, Camplejohn RS, Barnes DM, Millis RR, Allen D, Rubens RD, et al. DNA index, S-phase fraction, histological grade and prognosis in breast cancer. Br J Cancer 1990; 61:671-4.
18. Bergers E, Diest PJ van, Baak JPA. Reproducibility of semi-automated cell cycle analysis of flow cytometric DNA-histograms of fresh breast cancer material. Anal Cell Pathol 1995; 8:1-13.
19. Bergers E, Diest PJ van, Baak JPA. Inter-laboratory reproducibility of semi-automated cell cycle analysis of flow cytometric DNA-histograms obtained from fresh material of 1295 breast cancer cases. Hum Pathol In press.
20. Baak JPA, Diest PJ van, Ariens ATh, Beek MWPM van, Bellot SM, Fijnheer J, et al. The Multicenter Morphometric Mammary Carcinoma Project (MMMCP): a nationwide prospective study on reproducibility and prognostic power of routine quantitative assessments in The Netherlands. Pathol Res Pract 1989; 185:664-70.
21. Baak JPA, Dop H van, Kurver PHJ, Hermans JO. The value of morphometry to classic prognosticators in breast cancer. Cancer 1985; 56:374-84.
22. Diest PJ van, Baak JPA, Matze-Cok P, Wisse-Brekelmans ECM, Galen CM van, Kurver PHJ, et al. Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 1992; 23:603-7.
23. Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE, Hedley DW, et al. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993; 14:472-7.
24. Remvikos Y, Magdelénat H, Zajdela A. DNA flow cytometry applied to fine needle sampling of human breast cancer. Cancer 1988; 61:1629-34.
25. Christov K, Milev A, Todorov V. DNA aneuploidy and cell proliferation in breast tumors. Cancer 1989; 64:673-9.
26. Helin HJ, Helle MJ, Kallioniemi OP, Isola JJ. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Cancer 1989; 63:1761-7.
27. Bichel P, Skovgaard Poulsen H, Andersen J. Estrogen receptor content and ploidy of human mammary carcinoma. Cancer 1982; 50:1771-4.
28. Toikkanen S, Joensuu H, Klemi P. The prognostic significance of nuclear DNA content in invasive breast cancer: a study with long-term follow-up. Br J Cancer 1989; 60:693-700.
29. Baak JPA, Persijn JP. In search for the best qualitative microscopical or morphometrical predictor of oestrogen receptor in breast cancer. Pathol Res Pract 1984; 178:307-14.
30. Feichter GE, Mueller A, Kaufmann M, Haag D, Born IA, Abel U, et al. Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer. Int J Cancer 1988; 41:823-8.
31. Stål O, Wingren S, Carstensen J, Rutqvist LE, Skoog L, Klintenberg C, et al. Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variable in primary breast cancer. Eur J Cancer Clin Oncol 1989; 25:301-9.
32. Dressler LG, Seamer LC, Owens MA, Clark GM, McGuire WL. DNA-flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 1988; 61:420-7.
33. Bedrossian CWM, Raber M, Barlogie B. Flow cytometry and cytomorphology in primary resectable breast cancer. Anal Quant Cytol 1981; 3:112-6.
34. McDivitt RW, Stone KR, Craig RB, Palmer JO, Meyer JS, Bauer WC. A proposed classification of breast cancer based on kinetic information. Cancer 1986; 57:267-76.
35. Fossa SD, Thorud E, Shoaib MC, Pettersen EO, Hoie J, Scott Knudse O. DNA flow cytometry in primary breast carcinoma. Acta Pathol Microbiol Immunol Scand [a] 1984; 92:475-80.
36. Jakobsen A, Skovgaard Poulsen H, Lindegaard Madsen E, Ellebaek Petersen S, Sommer Hansen H. Ploidy level of human breast carcinoma: relation to histopathologic features and hormone receptor content. Acta Radial Oncol 1984; 23:103-7.
37. Kute TE, Muss HV, Cooper MR, Case LD, Buss D, Stanley V, et al. The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients. Cancer 1990; 66:1810-6.
38. Lewis WE. Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients. Cancer 1990; 65:2315-20.
39. Spyratos F, Briffod M, Gentile A, Brunet M, Brault C, Desplaces A. Flow cytometric study of DNA distribution in cytopunctures of benign and malignant breast lesions. Anal Quant Cytol Histol 1987; 9:485-94.
40. Taylor IW, Musgrove EA, Friedlander ML, Foo MS, Hedley DW. The influence of age on the DNA ploidy levels of breast tumours. Eur J Cancer Clin Oncol 1983; 19:623-8.
41. Thorud E, Fossa SD, Vaage S, Kaalhus O, Knudsen OS, Bormer O, et al. Primary breast cancer: flow cytometric DNA pattern in relation to clinical and histopathologic characteristics. Cancer 1986; 57:808-11.
42. Abandowitz HM, Ow KT, Hardy D, Keightley DD, Sarfaty A, Nash AR. Relationship between flow cytometric parameters, steroid receptors, and menopausal status in breast cancers. Oncology 1987; 44:24-9.
43. Raber MN, Barlogie B, Latreille J, Bedrossian C, Fritsche H, Blumenschein G. Ploidy, proliferative activity and estrogen receptor content in human breast cancer. Cytometry 1982; 3:36-41.
44. Redkar AA, Balsara BR, Bhisey AN, Mittra I. DNA analysis of breast cancer by flow cytometry & correlation with other prognostic parameters. Indian J Med Res 1992; 96:223-9.
45. Del Bino G, Silvestrini R, Zucconi MR, Marchese G, Valentinis B, Di Fronzo G, et al. DNA ploidy of human breast cancer. Anal Cell Pathol 1989; 1:215-23.
46. Moran RE, Black MM, Alpert L, Strauss HJ. Correlation of cell cycle kinetics, hormone receptors, histopathology and nodal status in human breast cancer. Cancer 1984; 54:1586-90.
47. Olszewski W, Darzynkiewicz Z, Rosen PP, Schwartz MK, Melamed MR. Flow cytometry of breast carcinoma: part I. relation of DNA ploidy level to histology and estrogen receptor. Cancer 1981; 48:980-4.
48. Ewers SB, Långström E, Baldetorp B, Killander D. Flow cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations. Cytometry 1984; 5:408-19.
49. Sigurdsson H, Baldetorp B, Borg A, Dalberg M, Fernö M, Killander D, et al. Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels. Br J Cancer 1990; 62:786-90.
50. Klintenberg C, Wallgren A, Bjelkenkrantz K, Cartenssen J, Humla S, Nordenskjöld B, et al. DNA distribution, cytosol estrogen receptors and axillary nodes as prognostic predictors in breast carcinoma. Acta Radiol Oncol 1985; 24:253-8.
51. Aasmundstad TA, Haugen OA. DNA ploidy in intraductal breast carcinoma. Eur J Cancer 1990; 26:956-9.
52. Stuart-Harris R, Hedley DW, Taylor IW, Levene AL, Smith IE. Tumour ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer. Br J Cancer 1985; 51:573-6.
53. Toikkanen S, Joensuu H, Klemi P. Nuclear DNA content as a prognostic factor in T1-2N0 breast cancer. Am J Clin Pathol 1990; 93:471-9.
54. Olszewski W, Darzynkiewicz Z, Rosen PP, Schwartz MK, Melamed MR. Flow cytometry of breast carcinoma: part II. relation of tumor cell cycle distribution to histology and estrogen receptor. Cancer 1981; 48:985-8.